Arteriotomy Closure Devices Market Report
First published: 12 October 2024 | Last updated: 25 May 2026 | Report Code: arteriotomy-closure-devices
Arteriotomy Closure Devices Market — USD 2.5 billion in 2023, Growing to USD 4.45B by 2033 at 5.8% CAGR
This report provides a comprehensive analysis of the Arteriotomy Closure Devices market, including current trends, growth opportunities, and detailed regional breakdowns. Insights forecast from 2023 to 2033 highlight market dynamics, key players, and future technologies shaping the industry.
Key Takeaways
- Global market expands from $2.50 Billion (2023) to $4.45 Billion (2033) with a 5.8% CAGR.
- Europe is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America grows from $0.82 Billion to $1.45 Billion between 2023 and 2033.
- Biodegradable and non-biodegradable materials, plus hospitals and ambulatory surgical centers, are central end-user and material segments.
Arteriotomy Closure Devices Market Report — Executive Summary
Europe remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The report examines drivers behind steady growth in arteriotomy closure devices, including increasing procedural volumes and broader adoption of minimally invasive techniques. Market value rises from $2.50 Billion in 2023 to $4.45 Billion in 2033 at a 5.8% CAGR. Europe is the largest regional market with specified growth from $0.89 Billion to $1.58 Billion. Key segments covered include device type, material, application, distribution channel, and end-user categories such as hospitals and ambulatory surgical centers. The competitive overview lists Abbott Laboratories, Cardica, Inc., and Medtronic among leading participants. Analysis addresses technological innovation, outpatient procedure migration, and regulatory considerations shaping product development and commercialization strategies.
Key Growth Drivers
- Rising volumes of cardiac and vascular procedures increase demand for reliable closure solutions.
- Shift toward minimally invasive surgery encourages adoption of deployable arteriotomy devices.
- Expansion of outpatient and ambulatory surgical care amplifies demand from non-hospital settings.
- Ongoing device design improvements and material innovations support broader clinical acceptance.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 5.8% |
| 2033 Market Size | $4.45 Billion |
| Top Companies | Abbott Laboratories, Cardica, Inc., Medtronic |
| Published Date | 12 October 2024 |
| Last Modified Date | 25 May 2026 |
Arteriotomy Closure Devices Market Overview
Customize Arteriotomy Closure Devices Market Report market research report
- ✔ Get in-depth analysis of Arteriotomy Closure Devices market size, growth, and forecasts.
- ✔ Understand Arteriotomy Closure Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Arteriotomy Closure Devices
What is the Market Size & CAGR of Arteriotomy Closure Devices Market Report market in 2023?
Arteriotomy Closure Devices Industry Analysis
Arteriotomy Closure Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Arteriotomy Closure Devices Market Report Market Analysis Report by Region
Europe Arteriotomy Closure Devices Market Report:
Europe is largest regional market, rising from $0.89 Billion in 2023 to $1.58 Billion in 2033. Growth aligns with wide clinical adoption of minimally invasive procedures and investments in outpatient surgical capabilities.Asia Pacific Arteriotomy Closure Devices Market Report:
Asia Pacific grows from $0.43 Billion in 2023 to $0.77 Billion in 2033. Expansion is linked to rising procedural volumes, improving access to care and gradual adoption of newer device technologies.North America Arteriotomy Closure Devices Market Report:
North America grows from $0.82 Billion in 2023 to $1.45 Billion in 2033. 82 Billion in 2023, growing to $1.45 Billion in 2033. Regional demand reflects high procedural volumes, established healthcare infrastructure and clinician preference for advanced closure technologies.South America Arteriotomy Closure Devices Market Report:
Latin America grows from $0.22 Billion in 2023 to $0.39 Billion in 2033. Market activity is supported by increasing surgical case numbers and gradual uptake of minimally invasive approaches.Middle East & Africa Arteriotomy Closure Devices Market Report:
Middle East and Africa grows from $0.15 Billion in 2023 to $0.26 Billion in 2033. Growth reflects expanding clinical services, rising demand for procedural safety and incremental technology adoption.Tell us your focus area and get a customized research report.
Research Methodology
Arteriotomy Closure Devices Market Analysis By Device Type
The market for Arteriotomy Closure Devices is categorized into manual, automated, and other devices. Manual devices hold a significant share of around 66% in 2023, expected to maintain this share through 2033, reflecting their established efficacy and adoption in surgical environments. Automated devices are also gaining traction, projected to grow from $0.61 billion in 2023 to $1.08 billion by 2033, driven by advancements in automation and robotic-assisted surgeries.
Arteriotomy Closure Devices Market Analysis By Application
Applications of Arteriotomy Closure Devices include cardiac surgery, vascular surgery, peripheral vascular interventions, and other procedures. Cardiac surgeries dominate with around 55% of the market in 2023, expanding due to the increasing number of cardiovascular operations. Vascular surgeries are also significant, anticipated to grow slowly but steadily as the need for vascular interventions rises.
Arteriotomy Closure Devices Market Analysis By End User
Hospitals remain the predominant end-user, with a market share of approximately 66.08% in 2023, ensuring continued growth as more complex procedures are performed. Ambulatory surgical centers are growing rapidly, projected to double their market share by 2033, reflecting a trend toward outpatient care.
Arteriotomy Closure Devices Market Analysis By Distribution Channel
Distribution channels for Arteriotomy Closure Devices include direct sales, distributors, and online sales. Direct sales dominate with a 66.08% share in 2023 due to established purchasing relationships with hospitals, while online sales are expected to increase in importance as e-commerce in healthcare expands.
Arteriotomy Closure Devices Market Analysis By Material
Materials used in Arteriotomy Closure Devices can be divided into biodegradable and non-biodegradable. Biodegradable materials capture a significant market share of 83.58%, driven by their benefits in preventing complications associated with foreign materials. Further advances in materials science are likely to enhance this segment's dominance in the coming years.
Arteriotomy Closure Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Arteriotomy Closure Devices Industry
Abbott Laboratories:
A leader in medical devices, Abbott specializes in advanced cardiovascular solutions, including innovative arteriotomy closure devices that enhance surgical outcomes.Cardica, Inc.:
Cardica is known for its innovative closure technologies and devices designed to streamline surgical procedures and improve recovery times for patients undergoing arterial interventions.Medtronic :
One of the largest medical device companies globally, Medtronic offers a comprehensive range of surgical products, including cutting-edge arteriotomy closure devices widely used in cardiac surgeries.We're grateful to work with incredible clients.
FAQs
What is the market size of the Arteriotomy Closure Devices Market Report in 2023?
The market size in 2023 is $2.50 Billion, reflecting current procedural demand and device adoption across clinical settings.
How big will the market be in 2033?
By 2033 the market reaches $4.45 Billion, based on projected adoption trends and increased procedural volumes over the forecast period.
What is CAGR for the forecast period?
The forecast period CAGR is 5.8%, representing compound annual growth from 2023 to 2033 as stated in the report data.
Is there a single fastest Growing region in the Arteriotomy Closure Devices Market Report market?
No single fastest-growing region is stated for the Arteriotomy Closure Devices Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top players?
Top companies named in the report are Abbott Laboratories, Cardica, Inc., and Medtronic, reflecting recognized market participants.
What end User segments are covered?
End-user segmentation includes hospitals, ambulatory surgical centers, and specialty clinics as specified subsegments in the report.
How are materials categorized in the report?
Materials are categorized as Biodegradable Materials and Non-Biodegradable Materials, reflecting product composition groupings used in analysis.
Who contributed to the research methodology?
Primary interviews with industry experts and secondary research via company reports and publications supported the report’s data and analysis.